Shanghai Medicilon (SHSE:688202) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688202 Shanghai Medicilon Inc SHSE:688202
68 GF Score
Price ¥103.10
GF Value ¥45.31
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Shanghai Medicilon Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

SHSE:688202
68GF Score
Shanghai Medicilon Inc SHSE:688202
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Medicilon (SHSE:688202) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Medicilon stock appears to be overvalued. The current stock price of ¥103.10 is trading 127.5% above its estimated GF Value™ of ¥45.31. GuruFocus considers Shanghai Medicilon to be Significantly Overvalued.

Key valuation signals for SHSE:688202:

  • Dividends Received:
  • GF Value™: ¥45.31 vs. price of ¥103.10 (127.5% above fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688202 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Medicilon Business Description

Address Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.
68GF Score

Get the complete analysis for SHSE:688202

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥103.10
Price
¥45.31
GF Value